These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 27823885)

  • 21. Trace Amines and Their Receptors.
    Gainetdinov RR; Hoener MC; Berry MD
    Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insights into the structure and pharmacology of the human trace amine-associated receptor 1 (hTAAR1): homology modelling and docking studies.
    Cichero E; Espinoza S; Gainetdinov RR; Brasili L; Fossa P
    Chem Biol Drug Des; 2013 Apr; 81(4):509-16. PubMed ID: 22883051
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
    Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AlphaFold accelerated discovery of psychotropic agonists targeting the trace amine-associated receptor 1.
    Díaz-Holguín A; Saarinen M; Vo DD; Sturchio A; Branzell N; Cabeza de Vaca I; Hu H; Mitjavila-Domènech N; Lindqvist A; Baranczewski P; Millan MJ; Yang Y; Carlsson J; Svenningsson P
    Sci Adv; 2024 Aug; 10(32):eadn1524. PubMed ID: 39110804
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacologic characterization of the cloned human trace amine-associated receptor1 (TAAR1) and evidence for species differences with the rat TAAR1.
    Wainscott DB; Little SP; Yin T; Tu Y; Rocco VP; He JX; Nelson DL
    J Pharmacol Exp Ther; 2007 Jan; 320(1):475-85. PubMed ID: 17038507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1.
    Cöster M; Biebermann H; Schöneberg T; Stäubert C
    Eur Thyroid J; 2015 Sep; 4(Suppl 1):9-20. PubMed ID: 26601069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inverse agonistic action of 3-iodothyronamine at the human trace amine-associated receptor 5.
    Dinter J; Mühlhaus J; Wienchol CL; Yi CX; Nürnberg D; Morin S; Grüters A; Köhrle J; Schöneberg T; Tschöp M; Krude H; Kleinau G; Biebermann H
    PLoS One; 2015; 10(2):e0117774. PubMed ID: 25706283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasodilator Effect of Trace Amines, 3-Iodothyronamine, and RO5263397 in the Rat Perfused Kidney: Comparison with Tryptamine.
    Jragh D; Chandrasekhar B; Yousif MHM; Oriowo MA
    Pharmacology; 2023; 108(4):368-378. PubMed ID: 37245501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TAAR1 and Psychostimulant Addiction.
    Liu J; Wu R; Li JX
    Cell Mol Neurobiol; 2020 Mar; 40(2):229-238. PubMed ID: 31974906
    [TBL] [Abstract][Full Text] [Related]  

  • 30. New Insights into the Potential Roles of 3-Iodothyronamine (T1AM) and Newly Developed Thyronamine-Like TAAR1 Agonists in Neuroprotection.
    Bellusci L; Laurino A; Sabatini M; Sestito S; Lenzi P; Raimondi L; Rapposelli S; Biagioni F; Fornai F; Salvetti A; Rossi L; Zucchi R; Chiellini G
    Front Pharmacol; 2017; 8():905. PubMed ID: 29311919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TAAR Agonists.
    Xu Z; Li Q
    Cell Mol Neurobiol; 2020 Mar; 40(2):257-272. PubMed ID: 31848873
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.
    Barak LS; Salahpour A; Zhang X; Masri B; Sotnikova TD; Ramsey AJ; Violin JD; Lefkowitz RJ; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2008 Sep; 74(3):585-594. PubMed ID: 18524885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Search for Structural Basis of Interactions of Biogenic Amines with Human TAAR1 and TAAR6 Receptors.
    Glyakina AV; Pavlov CD; Sopova JV; Gainetdinov RR; Leonova EI; Galzitskaya OV
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recognition of methamphetamine and other amines by trace amine receptor TAAR1.
    Liu H; Zheng Y; Wang Y; Wang Y; He X; Xu P; Huang S; Yuan Q; Zhang X; Wang L; Jiang K; Chen H; Li Z; Liu W; Wang S; Xu HE; Xu F
    Nature; 2023 Dec; 624(7992):663-671. PubMed ID: 37935377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In Vitro Characterization of Psychoactive Substances at Rat, Mouse, and Human Trace Amine-Associated Receptor 1.
    Simmler LD; Buchy D; Chaboz S; Hoener MC; Liechti ME
    J Pharmacol Exp Ther; 2016 Apr; 357(1):134-44. PubMed ID: 26791601
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of potential TAAR1 agonist targeting neurological and psychiatric disorders: An in silico approach.
    Garisetti V; Dhanabalan AK; Dasararaju G
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130528. PubMed ID: 38431013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Trace amine-associated receptors as emerging therapeutic targets.
    Sotnikova TD; Caron MG; Gainetdinov RR
    Mol Pharmacol; 2009 Aug; 76(2):229-35. PubMed ID: 19389919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trace amine-associated receptor 1 activation silences GSK3β signaling of TAAR1 and D2R heteromers.
    Harmeier A; Obermueller S; Meyer CA; Revel FG; Buchy D; Chaboz S; Dernick G; Wettstein JG; Iglesias A; Rolink A; Bettler B; Hoener MC
    Eur Neuropsychopharmacol; 2015 Nov; 25(11):2049-61. PubMed ID: 26372541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TAAR1 as an emerging target for the treatment of psychiatric disorders.
    Liu J; Wu R; Li JX
    Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAAR1 Modulates Cortical Glutamate NMDA Receptor Function.
    Espinoza S; Lignani G; Caffino L; Maggi S; Sukhanov I; Leo D; Mus L; Emanuele M; Ronzitti G; Harmeier A; Medrihan L; Sotnikova TD; Chieregatti E; Hoener MC; Benfenati F; Tucci V; Fumagalli F; Gainetdinov RR
    Neuropsychopharmacology; 2015 Aug; 40(9):2217-27. PubMed ID: 25749299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.